UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 995

Sortiert nach

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

JAMA : the journal of the American Medical Association, 2006-04, Vol.295 (14), p.1658

2006

Link zum Volltext

Verfügbarkeit prüfen

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

The New England journal of medicine, 2007-10, Vol.357 (15), p.1496-1506

2007

Link zum Volltext

Verfügbarkeit prüfen

Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3699-3704

2007

Link zum Volltext

Verfügbarkeit prüfen

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

Journal of clinical oncology, 2003-03, Vol.21 (6), p.976-983

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic Markers of Perifosine Efficacy

Clinical cancer research, 2007-12, Vol.13 (24), p.7421-7431

2007

Link zum Volltext

Verfügbarkeit prüfen

Bisphosphonates: game changers?

Oncology (Williston Park, N.Y.), 2015-01, Vol.29 (1), p.16, 42-42

Craig Henderson, I

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3893-3901

2004

Link zum Volltext

Verfügbarkeit prüfen

Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2061-2068

2004

Link zum Volltext

Verfügbarkeit prüfen

Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1934-1940

2005

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapy: a sea change in the treatment of cancer

Oncology (Williston Park, N.Y.), 2012-11, Vol.26 (11), p.1035, 1039-1039

Henderson, I Craig

2012

Link zum Volltext

Verfügbarkeit prüfen

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

Clinical cancer research, 2011-08, Vol.17 (15), p.5170-5178

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of HER2 Status by Fluorescence in Situ Hybridization and Immunohistochemistry to Predict Benefit From Dose Escalation of Adjuvant Doxorubicin-Based Therapy in Node-Positive Breast Cancer Patients

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4287-4297

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344

Journal of clinical oncology, 2005-01, Vol.23 (1), p.30-40

2005

Link zum Volltext

Verfügbarkeit prüfen

With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way

Oncology (Williston Park, N.Y.), 2017-05, Vol.31 (5), p.346-348

Henderson, I Craig

2017

Link zum Volltext

Verfügbarkeit prüfen

The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast Cancer

The New England journal of medicine, 1996-05, Vol.334 (21), p.1356-1361

1996

Link zum Volltext

Verfügbarkeit prüfen

Impact of High-Dose Chemotherapy on the Ability to Deliver Subsequent Local–Regional Radiotherapy for Breast Cancer: Analysis of Cancer and Leukemia Group B Protocol 9082

International journal of radiation oncology, biology, physics, 2010-04, Vol.76 (5), p.1305-1313

2010

Link zum Volltext

Verfügbarkeit prüfen

Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy

Expert review of anticancer therapy, 2007-07, Vol.7 (7), p.919-943

2007

Link zum Volltext

Verfügbarkeit prüfen

Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

The New England journal of medicine, 2004-09, Vol.351 (10), p.971-977

2004

Link zum Volltext

Verfügbarkeit prüfen

The relationship between prognostic and predictive factors in the management of breast cancer

Breast cancer research and treatment, 1998-01, Vol.52 (1-3), p.261-288

1998

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

JAMA : the journal of the American Medical Association, 2005-03, Vol.293 (9), p.1073

2005

Link zum Volltext

Verfügbarkeit prüfen

Can we abandon anthracyclines for early breast cancer patients?

Oncology (Williston Park, N.Y.), 2011-02, Vol.25 (2), p.115-127

Henderson, I Craig

2011

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy is not for everyone

Breast cancer research and treatment, 2010-08, Vol.123 (1), p.159-162

Henderson, I. Craig

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of Activation State of ErbB-2 (HER-2) on Response to Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil for Stage II, Node-Positive Breast Cancer: Study 8541 From the Cancer and Leukemia Group B

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2364-2372

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 995

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(753)
Mit Volltextzugriff
(870)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(988)
Japanisch
(90)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

Pharmacodynamic Markers of Perifosine Efficacy

Bisphosphonates: game changers?

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342

Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial

Targeted therapy: a sea change in the treatment of cancer

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

Comparison of HER2 Status by Fluorescence in Situ Hybridization and Immunohistochemistry to Predict Benefit From Dose Escalation of Adjuvant Doxorubicin-Based Therapy in Node-Positive Breast Cancer Patients

Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344

With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way

The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast Cancer

Impact of High-Dose Chemotherapy on the Ability to Deliver Subsequent Local–Regional Radiotherapy for Breast Cancer: Analysis of Cancer and Leukemia Group B Protocol 9082

Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy

Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

The relationship between prognostic and predictive factors in the management of breast cancer

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

Can we abandon anthracyclines for early breast cancer patients?

Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel

Adjuvant chemotherapy is not for everyone

Influence of Activation State of ErbB-2 (HER-2) on Response to Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil for Stage II, Node-Positive Breast Cancer: Study 8541 From the Cancer and Leukemia Group B

Suchergebnisse filtern